Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/28/2013 | WO2013040766A1 Method and vaccine capable of inducing broad spectrum immune response against hiv |
03/28/2013 | WO2013040721A1 Method and system for producing ozonated natural oils and the application thereof in the treatment of humans, animals and vegetables, and in aquaculture |
03/28/2013 | WO2013040648A1 Pneumococcal glpo immunogen |
03/28/2013 | WO2013040647A1 Novel antimicrobial compounds |
03/28/2013 | WO2013010218A9 Inhibition of clathrin |
03/28/2013 | WO2012177075A3 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections |
03/28/2013 | WO2012175587A3 Crystalline cefoperazone intermediate, process for its preparation and pharmaceutical use thereof |
03/28/2013 | WO2012173448A3 Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases |
03/28/2013 | WO2012172562A3 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation |
03/28/2013 | WO2012168949A3 A process for preparation of nevirapine |
03/28/2013 | WO2012165854A3 Long interfering dsrna simultaneously inducing an immune reaction and the inhibition of the expression of target genes |
03/28/2013 | WO2012162580A3 Anti-viral compounds |
03/28/2013 | WO2012159120A3 Gene therapy based strategy for treating hiv |
03/28/2013 | WO2012158789A3 Methods and compositions for inhibiting neddylation of proteins |
03/28/2013 | WO2012061395A3 Cytotoxic agents against cancer cells and uses thereof |
03/28/2013 | WO2012021991A8 Anti-viral carbamimidothioic acid esters |
03/28/2013 | WO2011158042A3 Ureido- pyrazole derivatives for use in the treatment of rhinovirus infections |
03/28/2013 | US20130079390 Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection |
03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
03/28/2013 | US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
03/28/2013 | US20130079317 Methods for treatment of diseases |
03/28/2013 | US20130079274 Pharmaceutical compositions for treating dysregulated inflammatory diseases |
03/28/2013 | US20130078286 Drug delivery system |
03/28/2013 | US20130078259 Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases |
03/28/2013 | US20130078214 Compounds for the Treatment of Hepatitis C |
03/28/2013 | CA2849822A1 Novel influenza hemagglutinin protein-based vaccines |
03/28/2013 | CA2849710A1 Cachexia treatment |
03/28/2013 | CA2849475A1 Novel betulinic acid derivatives with antiviral activity |
03/28/2013 | CA2849434A1 Influenza virus vaccines and uses thereof |
03/28/2013 | CA2846062A1 Shigella-derived vector and methods of using the same |
03/28/2013 | CA2845388A1 Beta-lactam compounds for enhancing t cell-mediated immune responses |
03/27/2013 | EP2573100A1 Total synthesis of the core tetrasaccharide of the lipopolysaccharide from Neisseria meningitidis |
03/27/2013 | EP2573090A1 (6,7-dihydro-2-nitro-5h-imidazol[2,1-b][1,3]oxazin-6-yl) amide compounds, preparation methods and uses thereof |
03/27/2013 | EP2573086A1 N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
03/27/2013 | EP2573085A1 N-[5-(aminosulfonyl)-4methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range |
03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
03/27/2013 | EP2573067A1 Aromatic butan-2-ol compounds, preparation methods and uses thereof |
03/27/2013 | EP2572712A2 Treatment of viral infections by modulation of host cell metabolic pathways |
03/27/2013 | EP2571990A2 Universal dengue virus sequences and methods of use |
03/27/2013 | EP2571898A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins |
03/27/2013 | EP2571882A1 Heterocyclic flaviviridae virus inhibitors |
03/27/2013 | EP2571871A1 Process for the preparation of chiral triazolones |
03/27/2013 | EP2571847A1 Process for the preparation of chiral hydrazides |
03/27/2013 | EP2571523A2 Latent human immunodeficiency virus reactivation |
03/27/2013 | CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
03/27/2013 | CN1370083B Ninovasive genetic immnization, expression products therefrom, and uses thereof |
03/27/2013 | CN1259141B PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
03/27/2013 | CN103003306A Antibodies |
03/27/2013 | CN103003302A Humanized and chimeric anti-properdin antibodies |
03/27/2013 | CN103003293A Aminoglycoside Derivatives |
03/27/2013 | CN103003271A Novel rhodanine derivatives, method for preparing same, and pharmaceutical composition for the prevention or treatment of AIDS containing the rhodanine derivatives as active ingredients |
03/27/2013 | CN103003236A Novel thiourea or urea derivative, preparation method thereof, and pharmaceutical composition for preventing or treating AIDS, containing same as active ingredient |
03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
03/27/2013 | CN103003233A Novel hydroxamic acid derivative |
03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
03/27/2013 | CN103002908A Mucosal vaccine |
03/27/2013 | CN102994520A Infectious bursal disease VP2 gene and application thereof |
03/27/2013 | CN102994460A Infectious bronchitis virus attenuated vaccine strain |
03/27/2013 | CN102994458A Porcine pseudorabies virus virulent strain, and gene deletion vaccine strain thereof and applications thereof |
03/27/2013 | CN102994457A Artificially-synthesized G4 phage and applications thereof |
03/27/2013 | CN102994456A Artificially-synthesized S13 phage and applications thereof |
03/27/2013 | CN102994410A Bacillus for inhibiting saprolegnia |
03/27/2013 | CN102994407A Flavobacterium strain and incision alginate lyase coding gene, preparation and application |
03/27/2013 | CN102993311A Infusion protein of IDB (Infectious Bursal Disease) virus VP2 protein and LTB (Leukotrienes B) and application thereof |
03/27/2013 | CN102993310A Fusion protein of IBD (Infectious Bursal Disease) VP2 and IL (Interleukin)-2 and application thereof |
03/27/2013 | CN102993308A Methicillin-resistant staphylococcus aureus (MRSA) vaccine recombinant protein antigen HI2 and preparation method and application thereof |
03/27/2013 | CN102993300A Duck tembusu virus polyclonal antibody and preparation method thereof |
03/27/2013 | CN102993277A Novel immunomodulatory protein, preparation method and application |
03/27/2013 | CN102993265A Immune receptor regulator couplet as well as preparation method and application thereof, coupling precursor for preparing immune receptor regulator couplet and compound for compounding coupling precursor |
03/27/2013 | CN102993250A C-3 substituted-9-deoxidized-9A-aza-9A-high erythromycin A derivative |
03/27/2013 | CN102993192A Oxazolidinone compound as well as preparation method and application thereof |
03/27/2013 | CN102993188A Fradimycin B as well as preparation method and application thereof |
03/27/2013 | CN102993170A Clinafloxacin derivative as well as preparation method and application thereof |
03/27/2013 | CN102993168A Streptonigrin analog and preparation method and application thereof |
03/27/2013 | CN102993148A Quercetin derivatives or analogs thereof, and application thereof |
03/27/2013 | CN102993124A Substituted piperazidines compound as well as preparation method and pharmaceutical use thereof |
03/27/2013 | CN102993115A 3, 5-disubstituted isoxazoline derivative and synthetic method and application thereof |
03/27/2013 | CN102993105A 1-methyl-2, 4-quinazoline diketone derivative and preparation method and application thereof |
03/27/2013 | CN102993095A Seven-element-ring polyhydroxy nitrone and preparation method and application thereof |
03/27/2013 | CN102989010A Porcine epidemic diarrhea virus genetic engineering subunit oral vaccine |
03/27/2013 | CN102989002A DOX-P micelle with anti-tumor drug resistance and preparation method thereof |
03/27/2013 | CN102988988A Pharmaceutical composition for treating pulmonary aspergillosis |
03/27/2013 | CN102988980A Vaccine dilution liquid for enhancing hog cholera lapinized vaccine immunity effect, and its use method |
03/27/2013 | CN102988978A Vaccine composition containing porcine circovirus type 2 antigen and haemophilus parasuis antigen, as well as preparation method and application thereof |
03/27/2013 | CN102988977A Multivalent vaccine |
03/27/2013 | CN102988976A Hepatitis B virus core antigen-DNA (deoxyribonucleic acid) compound vaccine and preparation method thereof |
03/27/2013 | CN102988975A Combined hepatitis A and B vaccine and preparation method thereof |
03/27/2013 | CN102988974A Method for preparing porcine pseudorabies live vaccine by using passage CEF (chicken embryo fibroblast) |
03/27/2013 | CN102988973A Nucleic acid vaccine for kio herpesvirus |
03/27/2013 | CN102988972A Method for producing porcine parvovirus inactivated vaccine by using torrent bioreactor |
03/27/2013 | CN102988971A Preparation method of porcine epidemic diarrhea virus genetic engineering subunit oral vaccine |
03/27/2013 | CN102988970A Foot-and-mouth disease purification vaccine, preparation method and applications thereof |
03/27/2013 | CN102988969A DNA vaccine for expressing avian reticuloendotheliosis virus gp90 gene as well as establishment method and application of gene |
03/27/2013 | CN102988968A Vaccine utilizing vibrio anguillarum flagellin and application thereof |
03/27/2013 | CN102988967A Preparation method of divalent composite adjuvant inactivated vaccine of Riemerella anatipestifer |
03/27/2013 | CN102988966A Method, vaccine composition and kit for exciting specific mucosal immunoreaction |
03/27/2013 | CN102988956A Method and reagent for preventing, diagnosing, treating and prognosing bacterial infection-related diseases |
03/27/2013 | CN102988934A Prescription of traditional Chinese medicine for treating beriberi and use method thereof |
03/27/2013 | CN102988929A Medicinal liquor for treating cold |